A retrospective, observational, cohort study assessing treatment response, using disease activity scores, to abatacept (ABA), TNF inhibitors (TNFi) or other non- TNFi targeted (t)DMARDs in patients with RA
Latest Information Update: 07 Feb 2020
At a glance
- Drugs Abatacept (Primary) ; Adalimumab; Baricitinib; Certolizumab pegol; Etanercept; Golimumab; Infliximab; Rituximab; Sarilumab; Tocilizumab; Tofacitinib
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
Most Recent Events
- 07 Feb 2020 New trial record